MedTrace Logo

Protocol Optimization in CT for the Quantification of BMD

NCT06305156 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 167

Last updated 2026-01-13

No results posted yet for this study

Summary

Bone mineral density is an important measurement to detect osteoporosis.

The goal of this clinical trial is to compare bone mineral density measurements in CT examinations and DXA scans. The main question it aims to answer is:

* How good is the measurement of bone mineral density in the new photon-counting CT in comparison to DXA
* How can we optimize the CT scan for bone mineral density

Participants will undergo:

* Clinically indicated CT scan on day of inclusion
* Study related DXA scan on a separate appointment

Conditions

  • Osteoporosis, Osteopenia
  • Bone Loss

Interventions

DIAGNOSTIC_TEST

Bone Mineral Density quantification

In the first visit, participants receive clinically indicated CT scan, where bone mineral density will be derived. In a second, study related visit, participants will receive a DXA scan for bone mineral quantifications.

Sponsors & Collaborators

  • Hatem Alkadhi

    lead OTHER

Principal Investigators

  • Hatem Alkadhi, MD, MPH · Diagnostic and Interventional Radiology, University Hospital Zurich

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-13
Primary Completion
2025-12-19
Completion
2025-12-19

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06305156 on ClinicalTrials.gov